BioSpace News Archive

GenSight Biologics announced the publication of a peer-reviewed article in the renowned American Journal of Ophthalmology focusing on pooled safety data from the 5 clinical studies with lenadogene nolparvovec.

Masimo announced the findings of a prospective study published in Pediatrics International in which Dr. Ya-Fei Liu and colleagues at Peking University First Hospital in Beijing evaluated the ability of noninvasive, continuous Masimo PVi®, alongside other dynamic parameters, to predict fluid responsiveness in children 1-3 years old who were undergoing major neurosurgery.

Prestige Biopharma Limited, a Singapore-based biopharmaceutical company, has developed a first-in-class diagnostic kit for pancreatic cancer.

Biotechnology startup Tiamat Sciences announced its $2 million seed-extension financing round led by 8090 Industries with participation from new and existing investors.

Clene Inc. and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative diseases, announced new results from exploratory analyses including delayed time to key clinical progression events in people living with amyotrophic lateral sclerosis who were treated with CNM-Au8® in the HEALEY ALS Platform Trial over the 6-months of the double-blind period.

Centogene N.V. today announced the appointment of Ian Rentsch as Chief Commercial Officer and General Manager - Pharma, who will join the Company on March 15, 2023.

Model N, Inc. announced the pricing of its offering of $220.0 million aggregate principal amount of convertible senior notes due 2028 in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended, or the Securities Act.

GT Medical Technologies, Inc. announced its latest roster of ELITE Brain Tumor Centers that have received the distinction for completing 10 or more GammaTile Therapy procedures in 2022.

Covalon Technologies Ltd. today is delighted to announce that Martin Goldfarb has joined its Board of Directors.

Theseus Pharmaceuticals, Inc. today announced business highlights and reported financial results for the fourth quarter and full year ended December 31, 2022.